NCT05618041 2025-06-24
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Recruiting
Clinical Trials
9 trialsNCT05064787 2024-05-24
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
Pack Health
Phase NA Completed
NCT05626400 2022-11-25
Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Recruiting
NCT05227898 2022-10-25
RESTORE
Blue Note Therapeutics
Phase NA Unknown
NCT04610125 2020-10-30
Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Unknown
NCT04497701 2020-08-04
Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Phase NA Unknown
NCT03811457 2019-01-22
Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma
UWELL Biopharma
Phase NA Completed
NCT03488160 2018-04-10
CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma
Sinobioway Cell Therapy Co., Ltd.
Phase NA Unknown
NCT02728882 2017-03-23
EECBL
Sinobioway Cell Therapy Co., Ltd.
Phase NA Unknown